Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

EYPT EyePoint Pharmaceuticals Inc

12,14

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:40:59

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more EyePoint Pharmaceuticals Charts.

News EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Donnerstag 16 Mai 2024 (5 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Mittwoch 8 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 6 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dienstag 16 April 2024 (1 Monat vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere EyePoint Pharmaceuticals Inc News-Artikel

Gold vs US Dollar

BNP Paribas (QX)

Energy Select Sector SPDR

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen